SUNGCHUN LEE

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology PHOENIX, AZ NPI 1033112818

General Payments — all program years on this page

$4,505.76

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 215
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $779.80 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $727.8736
Education $51.933

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $853.6338
2019 $611.7947
2020 $351.0719
2021 $397.0014
2022 $662.6825
2023 $849.7933
2024 $779.8039

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096682523 Novo Nordisk Inc $17.55 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096974499 Novo Nordisk Inc $21.67 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097048442 Novo Nordisk Inc $15.48 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097245426 Novo Nordisk Inc $21.98 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097289120 Novo Nordisk Inc $18.06 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097427160 Novo Nordisk Inc $18.57 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097708893 Novo Nordisk Inc $22.08 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105228030 AstraZeneca Pharmaceuticals LP $21.27 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105282694 AstraZeneca Pharmaceuticals LP $16.50 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846610 OPKO Pharmaceuticals, LLC $15.06 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846612 OPKO Pharmaceuticals, LLC $13.23 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846614 OPKO Pharmaceuticals, LLC $19.84 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846616 OPKO Pharmaceuticals, LLC $19.22 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846618 OPKO Pharmaceuticals, LLC $20.26 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846620 OPKO Pharmaceuticals, LLC $18.84 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846622 OPKO Pharmaceuticals, LLC $1.19 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846624 OPKO Pharmaceuticals, LLC $6.86 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846626 OPKO Pharmaceuticals, LLC $18.15 10/29/2024 Education Undisputed 01/23/2026 View at CMS
1115860670 Amgen Inc. $16.48 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115860679 Amgen Inc. $19.28 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115860688 Amgen Inc. $17.63 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117843781 Boehringer Ingelheim Pharmaceuticals, Inc. $14.60 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117843783 Boehringer Ingelheim Pharmaceuticals, Inc. $15.86 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117843785 Boehringer Ingelheim Pharmaceuticals, Inc. $16.10 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117843787 Boehringer Ingelheim Pharmaceuticals, Inc. $18.09 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117843789 Boehringer Ingelheim Pharmaceuticals, Inc. $27.49 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929341 Otsuka America Pharmaceutical, Inc. $23.12 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929343 Otsuka America Pharmaceutical, Inc. $21.72 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929345 Otsuka America Pharmaceutical, Inc. $21.72 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929347 Otsuka America Pharmaceutical, Inc. $17.49 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929349 Otsuka America Pharmaceutical, Inc. $16.95 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929351 Otsuka America Pharmaceutical, Inc. $23.30 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118929353 Otsuka America Pharmaceutical, Inc. $21.72 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120101205 Kerecis Limited $96.70 12/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135435287 Lilly USA, LLC $18.76 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141516749 CALLIDITAS THERAPEUTICS US INC. $14.46 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146691844 Ardelyx, Inc. $18.74 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149936910 Travere Therapeutics, Inc. $16.89 04/08/2024 Education Undisputed 01/23/2026 View at CMS
1149936914 Travere Therapeutics, Inc. $16.89 08/19/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.